1h Free Analyst Time
The publisher has been monitoring the CRISPR technology market and it is poised to grow by $ 2.88 bn during 2022-2026, accelerating at a CAGR of 19.34% during the forecast period. The report on the CRISPR technology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing demand for treatment of genetic diseases, rising genome editing across biotechnology, medical, and agriculture industries, and increasing R&D activities in CRISPR technology.
The CRISPR technology market analysis includes the application segment and geographic landscape.
The analyst's CRISPR technology market is segmented as below:
By Application:
- Biological application
- Agricultural application
- Industrial application
- Others
By Geographical Landscape:
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the advent of CRISPR/CAS9 as one of the prime reasons driving the CRISPR technology market growth during the next few years. Also, growing demand for innovative therapeutic gene therapy techniques and increasing venture funding will lead to sizable demand in the market.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The report on CRISPR technology market covers the following areas:
- CRISPR technology market sizing
- CRISPR technology market forecast
- CRISPR technology market industry analysis
The analyst's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading CRISPR technology market vendors that include Addgene Inc., Agilent Technologies Inc., Applied StemCell Inc., Caribou Biosciences Inc., Cellecta Inc., CRISPR Therapeutics AG, Danaher Corp., Editas Medicine Inc., GeneCopoeia Inc., GenScript Biotech Corp., Intellia Therapeutics Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, New England Biolabs Inc., Novartis AG, OriGene Technologies Inc., PerkinElmer Inc., Synthego Corp., and Thermo Fisher Scientific Inc. Also, the CRISPR technology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Application
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
Exhibit 132: Thermo Fisher S
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global CRISPR technology market: Addgene Inc., Agilent Technologies Inc., Applied StemCell Inc., Caribou Biosciences Inc., Cellecta Inc., CRISPR Therapeutics AG, Danaher Corp., Editas Medicine Inc., GeneCopoeia Inc., GenScript Biotech Corp., Intellia Therapeutics Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, New England Biolabs Inc., Novartis AG, OriGene Technologies Inc., PerkinElmer Inc., Synthego Corp., and Thermo Fisher Scientific Inc.Commenting on the report, an analyst said: "The latest trend gaining momentum in the market is the advent of CRISPR/CAS9."
According to the report, one of the major drivers for this market is the increasing demand for treatment of genetic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Addgene Inc.
- Agilent Technologies Inc.
- Applied StemCell Inc.
- Caribou Biosciences Inc.
- Cellecta Inc.
- CRISPR Therapeutics AG
- Danaher Corp.
- Editas Medicine Inc.
- GeneCopoeia Inc.
- GenScript Biotech Corp.
- Intellia Therapeutics Inc.
- Lonza Group Ltd.
- Merck KGaA
- Mirus Bio LLC
- New England Biolabs Inc.
- Novartis AG
- OriGene Technologies Inc.
- PerkinElmer Inc.
- Synthego Corp.
- Thermo Fisher Scientific Inc.
